Cipla is a leading global pharmaceutical company specializing in branded and generic medicines, APIs, and biotechnology across over 80 countries. Known for its commitment to affordable healthcare and innovation, Cipla operates across a vast network of manufacturing plants, supply chains, R&D divisions, and marketing units.
Cipla’s fragmented data ecosystem was limiting its ability to drive actionable business insights for both marketing and operational excellence.
Despite these hurdles, Cipla aimed to create a seamless experience for its users, reinforcing its commitment to innovation and accessibility in healthcare.
INT. implemented a centralized Data Engineering & Business Intelligence (BI) solution to unify Cipla’s operational and marketing data, enabling real-time insights, cost efficiencies, and improved marketing ROI.
INT.’s Data Engineering & Business Intelligence transformation delivered measurable business benefits across Cipla’s marketing and operational domains:
Higher ROI on marketing campaigns
Reduction in operational costs
From our point of view, INT. obviously helped us create value. When we started out with a product that barely worked. Now we actually have a mature product used by thousands of users at hundreds of sites.